Monoclonal Antibodies: A Segment of Major Growth
Topics: Antibody Technologies
|
World Biological Drugs Market 2011-2021
Topics: Antibody Technologies, Biopharmaceuticals
Regions: Global
|
Apoptosis in Oncology: Drug Pipeline Update 2011
Topics: Antibody Technologies, Oncology/Hematology
|
Angiongenesis Inhibitors and Stimulators
Topics: Research & Development, Antibody Technologies, Drug Discovery, Oncology/Hematology
Regions: Global
|
Antibodies in Oncology: Drug Pipeline Update 2011
Topics: Antibody Technologies, Oncology/Hematology
|
Competitor Analysis: Cancer Antibodies in Early Clinical Development
Topics: Research & Development, Antibody Technologies
|
Applied Immune Technologies Private Vendor Watchlist Profile: Antibody-Based Drug Development and Target Discovery
Topics: Antibody Technologies
|
Competitor Analysis: Antibody Therapy of Inflammatory and Autoimmune Diseases
Topics: Antibody Technologies, Autoimmune
|
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Topics: Gene Therapy, Antibody Technologies, Antisense & RNAi Technology, Nanomedicine, Drug Delivery
|
Antibody Technology Companies 2010
Topics: Biotechnology Company Reports, Antibody Technologies
|
Global Monoclonal Antibody Market Analysis
Topics: Antibody Technologies
Regions: Global
|
Antibody Pipeline Database: 1-Year Subscription
Topics: Antibody Technologies
|
Monoclonal Antibodies: 2010
Topics: Antibody Technologies
|
Competitor Analysis: Biosimilar and Biobetter/Biosuperior Antibodies
Topics: Biosimilars, Antibody Technologies
|
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Topics: Antibody Technologies, Rheumatology/Arthritis
|
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
Topics: Antibody Technologies, Biopharmaceuticals
|
Innovative Technology Platforms: How They Are Paying Off for Big Pharma and Biotech
Topics: Research & Development, Antibody Technologies, Research & Development
|
Monoclonal Antibodies Against Digestive System Cancers
Topics: Antibody Technologies, Oncology/Hematology, Gastrointestinal
|
Cancer Targeted Therapies and Immunotherapies Market Forecast
Topics: Antibody Technologies, Oncology/Hematology
|
Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
Topics: Antibody Technologies, Oncology/Hematology
|
Protein Drugs
Topics: Proteomics, Antibody Technologies
Regions: Global
|
Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects
Topics: Proteomics, Antibody Technologies
|
Competitor Analysis: Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease
Topics: Antibody Technologies, Alzheimer's Disease, Vaccines
|
Therapeutic Monoclonal Antibody Production
Topics: Antibody Technologies
|
Anti-CD20 Monoclonal Antibodies
Topics: Antibody Technologies
Regions: Global
|
Competitor Analysis: Anti-Infective Antibodies
Topics: Antibody Technologies
|
Closed Drug Transfer for Oncology Therapeutics
Topics: Antibody Technologies, Regulation & Policy, Research & Development, Oncology/Hematology
|
Competitor Analysis: P. aeruginosa Vaccines and Therapeutics
Topics: Antibody Technologies, Vaccines
|
Biotechnologies for Medical Applications: Global Markets
Topics: Antibody Technologies, Stem Cell, Nanomedicine, Vaccines, Drug Discovery
Regions: Global
|
Special Report: Can New Therapies Unseat Traditional Chemotherapy Regimens in Acute Myelogenous Leukemia?
Topics: Research & Development, Antibody Technologies, Research & Development, Oncology/Hematology
|
Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place
Topics: Antibody Technologies, Research & Development, Drug Delivery, Women's Health, Oncology/Hematology
|
Biological Therapies for Cancer: Technologies and Global Markets
Topics: Research & Development, Antibody Technologies, Vaccines, Oncology/Hematology
Regions: Global
|
Portfolio Analytics in the Pancreatic Cancer Pipeline and Portfolio Planning - High Unmet Medical Need but Where to Target?
Topics: Research & Development, Antibody Technologies, Research & Development, Drug Discovery, Oncology/Hematology
|
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
Topics: Antibody Technologies, Antisense & RNAi Technology, Biomarkers, Biopharmaceuticals
|
Antibody Drug Target Atlas In Oncology - Where To Commercialize In A Crowded Market Place?
Topics: Antibody Technologies, Hematology & Oncology, Oncology/Hematology
|
Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates
Topics: Research & Development, Antibody Technologies, Biologics
|
Patent map and technology intelligence report. Peptides
Topics: Antibody Technologies, Drug Discovery
|
Chinese Markets for Monoclonal Antibody
Topics: Antibody Technologies
Regions: China
|
Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
Topics: Antibody Technologies, Vaccines, Cancer Vaccines
|
Competitor Analysis Neurotrophic Growth Factors
Topics: Proteomics, Tissue Engineering, Antibody Technologies
|
The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Topics: Antibody Technologies
|
Apoptotic Therapeutics in Oncology - Where to Commercialize?
Topics: Antibody Technologies, Drug Discovery, Oncology/Hematology
|
Monoclonal antibodies: 2009 update
Topics: Research & Development, Antibody Technologies
|
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
Topics: Antibody Technologies, Drug Discovery
|
Regenerative Medicines: Bone and Joint Applications
Topics: Tissue Engineering, Biomaterials, Antibody Technologies, Regenerative Medicine, Orthopedics, Orthopedics
|
Biochips for Life Science Research, Diagnostics and Drug R&D
Topics: General Biotechnology, Genomics, Informatics, Antibody Technologies, Microarray , In Vitro Diagnostics, Molecular Assays, Research & Development
|
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
Topics: Research & Development, Antibody Technologies
|
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach
Topics: Genomics, Antibody Technologies, Biomarkers, Personalized Medicine
|
The 2010-2015 World Outlook for Monoclonal Antibody (MAb)-Based Products
Topics: Antibody Technologies
Regions: Global
|
The 2010-2015 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
Topics: Antibody Technologies
Regions: Global
|
